Rainbow trout derived polypeptide extract and its preparation method and application

By extracting peptide extracts from different components of rainbow trout, the problem of waste in fish processing is solved, and products with gonadotropin development, immunity improvement, anemia and anti-fatigue functions are provided, which improves rainbow trout farming income is improved, and it is shown that The effect after the combination is better than the innovation of prediction function.

CN118667909BActive Publication Date: 2024-11-15NANJING XINNUO FOOD TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411175891.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-26
Publication Date
2024-11-15
Estimated Expiration
2044-08-26

AI Technical Summary

Technical Problem

A lot of waste in the processing process of rainbow trout, especially the fish bones and fish internal organs, are rich in collagen, enzymes and active peptides, which are not effectively utilized, resulting in the failure to fully increase the breeding income.

Method used

Extract the polypeptide extract of rainbow trout source, and prepare the different components such as fish meat, fish bones, fish hearts, fish liver, fish belly, fish skin, fish bladder and fish head. Polypeptide extract that develops gonadotropism, promotes immune enhancement, improves anemia and anti-fatigue function.

Benefits of technology

Improves the breeding income of rainbow trout, provides high-efficiency ingredients used in cosmetics, health products and drugs, showing novel effects that are not exactly the same as the predicted function or are not simply superimposed, especially extracted from fish hearts, livers, belly, The polypeptide extract of the bladder is more effective.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118667909B_ABST
    Figure CN118667909B_ABST
Patent Text Reader

Abstract

The present application discloses a rainbow trout-derived polypeptide extract and its preparation method and application, belonging to the technical field of polypeptides and health foods. The rainbow trout-derived polypeptide extract is extracted from the fish meat, fish oil, fish bones, fish heart, fish liver, fish belly (fish stomach), fish skin, fish bladder and fish head of rainbow trout, and is partially mixed. After verification, it is found that it has the active functions of gonadotropin development, promoting immunity, improving anemia and anti-fatigue, etc. It can be used to prepare cosmetics, health products and even medicines, which increases the breeding income of rainbow trout.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application belongs to the technical field of polypeptides and health foods, and specifically relates to a rainbow trout-derived polypeptide extract and a preparation method and application thereof. Background Art

[0002] Rainbow trout (scientific name: Oncorhynchus mykiss ) is a fish of the genus Salmon in the family Salmonidae. It is a fish with high economic benefits, but at the same time it has high requirements for breeding conditions such as water quality. When rainbow trout is processed and eaten by humans, fish bones and fish viscera, which account for about 50% of the total weight, will be discarded, which causes huge waste. Previous studies have shown that fish bones and fish skin are rich in collagen, while fish brains and fish viscera may contain a variety of enzymes, hormones and active peptides. If these protein products can be screened and used in the development of cosmetics, health products and even drugs, it will greatly increase the breeding benefits of rainbow trout. Summary of the invention

[0003] 1. Purpose of the Invention

[0004] The purpose of the present invention is to provide a rainbow trout-derived polypeptide extract and a preparation method and application thereof. The rainbow trout-derived polypeptide extract is extracted from different components of rainbow trout, such as fish meat, fish oil, fish bones, fish heart, fish liver, fish belly (fish stomach), fish skin, fish bladder and fish head, and has active functions such as gonadotropin development, promoting immunity, improving anemia and / or resisting fatigue, and can be used to prepare cosmetics, health products and even medicines, thereby increasing the breeding income of rainbow trout.

[0005] 2. Technical solution

[0006] In order to achieve the above invention objectives, the technical solutions adopted in this application are as follows:

[0007] The present application provides a rainbow trout-derived polypeptide extract, which is extracted from any of the following mixed rainbow trout components:

[0008] (1) Rainbow trout meat, bones and heads;

[0009] (2) Heart, liver, belly and bladder of rainbow trout;

[0010] (3) Rainbow trout meat, bones, skin and head.

[0011] Furthermore, in the above-mentioned rainbow trout-derived polypeptide extract, the mass ratio of each component is (0.8~1.2):1.

[0012] Furthermore, in the above-mentioned rainbow trout-derived polypeptide extract, the mass ratio of each component is 1:1.

[0013] Furthermore, the above-mentioned rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones and heads.

[0014] Furthermore, the above-mentioned rainbow trout-derived polypeptide extract is extracted from the heart, liver, belly and bladder of rainbow trout.

[0015] Furthermore, the above-mentioned rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones, skin and head.

[0016] The present application provides a method for preparing the above-mentioned rainbow trout-derived polypeptide extract, which comprises the steps of raw material pretreatment, enzymatic hydrolysis, defatting and deodorization, membrane filtration and sterilization, concentration, spray drying, etc., and specifically comprises:

[0017] (1) Raw material pretreatment: the protein raw material (a certain component of rainbow trout or a mixture of several components) is thawed naturally at room temperature, the thawed protein raw material is repeatedly rinsed to remove blood and other impurities, and then the rinsed protein raw material is passed through a meat grinder and a colloid mill to make it fluid, thereby obtaining a fluid protein raw material; if the protein raw material is fresh, rather than frozen, it is directly rinsed to remove blood and other impurities, and then the rinsed protein raw material is passed through a meat grinder and a colloid mill;

[0018] (2) Enzymatic hydrolysis: Place the fluid protein raw material into an enzymatic hydrolysis tank, and add water at a mass ratio of protein raw material to water of 1:(1-3); heat the enzymatic hydrolysis tank to 56-60°C, add the composite protease, and continue to stir at this temperature for 3-4 hours. During this process, the protein raw material is enzymatically hydrolyzed into protein peptides, completing the enzymatic hydrolysis; then heat to 100-120°C and stir for 40-60 min to inactivate the enzyme, and obtain an enzymatic hydrolyzate liquid;

[0019] (3) Defatting and deodorizing: The enzymatic hydrolyzate liquid is sieved and centrifuged (12000~16000 r / min) to remove impurities such as broken bones (if any) to obtain a protein polypeptide liquid; the protein polypeptide liquid is placed in an oil-water separation centrifuge and centrifuged at 8000~10000 r / min to perform defatting treatment to obtain a protein polypeptide clear liquid; the bitter and fishy substances and color in the protein polypeptide clear liquid are removed by activated carbon adsorption to finally obtain a polypeptide liquid; in this step, the separation and purification of the protein polypeptide is simultaneously completed;

[0020] (4) Membrane filtration sterilization: Use a microfiltration or ultrafiltration device with a membrane pore size of 0.05-0.1 μm, filter at an operating pressure of 0.2Mpa-0.4Mpa and a temperature of 30-80°C to obtain a clear membrane-filtered polypeptide liquid;

[0021] (5) Concentration: Use a double-effect falling film evaporator to evaporate and concentrate the membrane filtered polypeptide liquid at a steam pressure of 0.1±0.02 MPa and 40~80°C until the solid content of the concentrate is 20%~50%;

[0022] (6) Spray drying: The concentrated liquid is spray dried using a spray drying device. The drying conditions are set at an inlet temperature of 160-180°C and an outlet temperature of 80-90°C to obtain a small molecule, high-purity rainbow trout-derived polypeptide powder, i.e., a rainbow trout-derived polypeptide extract.

[0023] Furthermore, in the above enzymolysis, the mass ratio of the protein raw material to water is 1:1, 1:2 or 1:3. Furthermore, in the above enzymolysis, the mass ratio of the protein raw material to water is 1:2.

[0024] Furthermore, in the above enzymolysis, the enzymolysis temperature is 56, 57, 58, 59 or 60° C. Further, in the above enzymolysis, the enzymolysis temperature is 58° C.

[0025] Furthermore, in the above enzymatic hydrolysis, the added amount of the composite protease is 0.2% by weight of the protein raw material, and can also be added according to the instructions for use of the composite protease.

[0026] Furthermore, in the above enzymatic hydrolysis, the enzymatic hydrolysis time is 3 h.

[0027] Furthermore, in the above enzymatic hydrolysis, the enzyme inactivation temperature is 100°C.

[0028] Furthermore, in the above enzymatic hydrolysis, the enzyme inactivation stirring time is 60 min.

[0029] Furthermore, in the above-mentioned defatting and deodorizing, 6% activated carbon powder is used and heated to not less than 80° C. for adsorption.

[0030] Furthermore, the above method may also include: packaging the polypeptide peptide powder into finished products in a clean room for easy sale, etc.

[0031] The present application also provides the use of the above-mentioned rainbow trout-derived polypeptide extract in the preparation of drugs or foods for gonadotropin development, promoting immunity, improving anemia and / or resisting fatigue.

[0032] Furthermore, the rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones and heads, and is used to prepare medicines or foods for promoting immunity and / or improving anemia.

[0033] Furthermore, the above-mentioned rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones and heads, and is used to prepare medicines or foods for promoting immunity.

[0034] Furthermore, the rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones and heads, and is used to prepare medicines or foods for improving anemia.

[0035] Furthermore, the above-mentioned rainbow trout-derived polypeptide extract is extracted from the heart, liver, belly and bladder of rainbow trout, and is used to prepare medicines or foods for gonadotropin development, promoting immunity, improving anemia and / or resisting fatigue.

[0036] Furthermore, the above-mentioned rainbow trout-derived polypeptide extract is extracted from the heart, liver, belly and bladder of rainbow trout, and is used to prepare gonadotropin-enhancing drugs or foods.

[0037] Furthermore, the above-mentioned rainbow trout-derived polypeptide extract is extracted from the heart, liver, belly and bladder of rainbow trout, and is used to prepare medicines or foods for promoting immunity.

[0038] Furthermore, the rainbow trout-derived polypeptide extract is extracted from the heart, liver, belly and bladder of rainbow trout, and is used to prepare medicine or food for improving anemia.

[0039] Furthermore, the rainbow trout-derived polypeptide extract is extracted from the heart, liver, belly and bladder of rainbow trout and is used to prepare anti-fatigue medicine or food.

[0040] Furthermore, the above-mentioned rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones, skin and head, and is used to prepare medicines or foods for gonadotropin development, promoting immunity, improving anemia and / or resisting fatigue.

[0041] Furthermore, the rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones, skin and head, and is used to prepare gonadotropin-enhancing drugs or foods.

[0042] Furthermore, the above-mentioned rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones, skin and head, and is used to prepare medicines or foods for promoting immunity.

[0043] Furthermore, the rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones, skin and head, and is used to prepare medicine or food for improving anemia.

[0044] Furthermore, the rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones, skin and head, and is used to prepare anti-fatigue medicine or food.

[0045] The present application also provides a pharmaceutical composition, which includes the above-mentioned rainbow trout-derived polypeptide extract and has the effects of gonadotropin development, promoting immunity, improving anemia and / or resisting fatigue.

[0046] The present application also provides a health food, which includes the above-mentioned rainbow trout-derived polypeptide extract and has the effects of gonadotropin development, promoting immunity, improving anemia and / or resisting fatigue.

[0047] 3. Beneficial effects

[0048] Compared with the prior art, the present application has the following beneficial effects:

[0049] (1) The present application provides a rainbow trout-derived polypeptide extract and a preparation method and application thereof. The protein content, i.e., protein composition analysis, of rainbow trout meat, fish oil, fish bones, fish heart, fish liver, fish maw (fish stomach), fish skin, fish bladder, and fish head is analyzed. The functions of the protein polypeptides of each component of rainbow trout are predicted based on the functions recorded in the UniProt database. However, the inventors also found that the polypeptide extracts extracted after combining different components are not completely the same as the predicted functions of each component, or their effects are not simply the sum of the components. For example, in the protein sequencing and bioinformatics analysis of the components of rainbow trout, it was predicted that rainbow trout bones and fish skin may have the effect of improving male gonadal development. However, the experimental results show that polypeptide extract 2 extracted from rainbow trout heart, liver, maw, and fish bladder is more effective than polypeptide extract 1 extracted from rainbow trout meat, bones, and head and polypeptide extract 3 extracted from rainbow trout meat, bones, skin, and head.

[0050] (2) The rainbow trout-derived polypeptide extract provided in the present application, and its preparation method and application, the rainbow trout-derived polypeptide extract is extracted from different components of rainbow trout meat, fish oil, fish bones, fish heart, fish liver, fish belly (fish stomach), fish skin, fish bladder and fish head, etc., and has been demonstrated by the inventors to have the active functions of gonadotropin development, promoting immunity, improving anemia and resisting fatigue, etc., and can be used to prepare cosmetics, health products and even medicines, thereby increasing the breeding income of rainbow trout. BRIEF DESCRIPTION OF THE DRAWINGS

[0051] Figure 1 This is the CCK8 result of TM4 gonad development model cells.

[0052] Figure 2 These are the CCK8 results of TM4 gonad development model cells treated with androgen, androgen inhibitor, and peptide samples 2, 3, and 1, respectively.

[0053] Figure 3 These are the WB results for AMH and SOX9 gene expression after TM4 gonad development model cells were treated with peptide samples 1, 2, and 3, respectively.

[0054] Figure 4 These are the RT-qPCR results for AMH and SOX9 gene transcription after treating TM4 gonad development model cells with peptide samples 1, 2, and 3, respectively.

[0055] Figure 5 This is the result of the effect of different concentrations of peptide sample 1 on the proliferation of RAW264.7 cells treated with LPS.

[0056] Figure 6 This is the result of CCK8 detecting the effect of polypeptide samples 1, 2, and 3 on the proliferation of RAW264.7 cells treated with LPS.

[0057] Figure 7 This is the result of neutral red detection of the effects of peptide samples 1, 2, and 3 on RAW264.7 cells after LPS treatment.

[0058] Figure 8 These are the results of the effects of NO detection polypeptide samples 1, 2, and 3 on RAW264.7 cells after LPS treatment.

[0059] Fig. 9 The results are from flow cytometry identification of hematopoietic stem cells extracted from fetal mouse liver using flow cytometry antibodies such as Sca-1.

[0060] Fig.10 The results are flow cytometry identification results after the red blood cells pre-induced for 10 days were treated with peptide samples 1, 2, and 3 for 24 hours.

[0061] Fig.11 The WB results of GATA1 gene expression were obtained after the erythrocytes pre-induced for 10 days were treated with peptide samples 1, 2, and 3 for 24 hours.

[0062] Fig.12 The RT-qPCR results of FOG1 gene transcription were obtained after the erythrocytes pre-induced for 10 days were treated with peptide samples 1, 2, and 3 for 24 hours.

[0063] Fig.13 RT-qPCR results for the transcription of genes ANP and Myh7 after H9c2 cells were treated with ISO.

[0064] Fig.14 These are the RT-qPCR results for ANP and Myh7 transcription after the anti-fatigue model cells were treated with peptide samples 1, 2, and 3 for 24 h and 36 h, respectively.

[0065] Fig.15 The WB results of LC3 expression after H9c2 anti-fatigue model cells were treated with peptide samples 1, 2, and 3 for 24 h (left) and 36 h (right).

[0066] Fig.16These are the WB results for BCL2 expression after H9c2 anti-fatigue model cells were treated with peptide samples 1, 2, and 3 for 24 h (left) and 36 h (right). DETAILED DESCRIPTION

[0067] The present application is further described below in conjunction with specific embodiments.

[0068] It should be noted that the terms such as "upper", "lower", "left", "right", "middle", etc. cited in this specification are only for the convenience of description and are not used to limit the scope of implementation. Changes or adjustments to their relative relationships should be regarded as the scope of implementation of this application without substantially changing the technical content.

[0069] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which this application belongs; the term "and / or" used herein includes any and all combinations of one or more of the associated listed items.

[0070] If the specific conditions are not specified in the examples, the experiments were carried out under conventional conditions or conditions recommended by the manufacturer. If the manufacturers of the reagents or instruments are not specified, they are all conventional products that can be purchased commercially.

[0071] As used herein, the term "about" is used to provide flexibility and imprecision associated with a given term, measurement or value. The degree of flexibility for a particular variable can be easily determined by one skilled in the art.

[0072] As used herein, the term "at least one of" is intended to be synonymous with "one or more of." For example, "at least one of A, B, and C" expressly includes only A, only B, only C, and combinations of each thereof.

[0073] Concentration, amount and other numerical data can be presented in range format herein.It should be understood that such range format is used only for convenience and brevity, and should be flexibly interpreted as not only including the numerical value clearly stated as the range limit, but also including all individual numerical values ​​or sub-ranges contained in the range, just as each numerical value and sub-range are clearly stated.For example, the numerical range of about 1 to about 4.5 should be interpreted as not only including the limit value of 1 to about 4.5 clearly stated, but also including individual numbers (such as 2,3,4) and sub-ranges (such as 1 to 3, 2 to 4, etc.).The same principle is applicable to the range of only narrating a numerical value, such as "less than about 4.5", which should be interpreted as including all the above-mentioned values ​​and ranges.In addition, no matter how the breadth of the described range or feature is, this interpretation should be applied.

[0074] In this application, the cell information used in the experiment is shown in Table 1:

[0075] Table 1 Cell information used in this application

[0076]

[0077] In this application, the main experimental instruments used in the experiment are shown in Table 2:

[0078] Table 2 Main experimental instruments used in this application

[0079]

[0080] In this application, unless otherwise specified, cell recovery and culture include:

[0081] Take the cells frozen in the -80℃ refrigerator, thaw in a 37℃ water bath, transfer the cells in the cryopreserved tube together with the cryopreservation solution into a new sterile EP tube, centrifuge at 1000 rpm for 5 min at room temperature, and discard the supernatant; take a small amount of cell culture medium preheated at 37℃ for 30 min in advance to gently resuspend the cells, transfer to a T25 cell flask to which a small amount of cell culture medium has been added, add cell culture medium until the total volume of the culture solution in the T25 cell flask is 5 mL, place in a 5% CO2 incubator, and culture at 37℃.

[0082] In this application, unless otherwise specified, Western Blot (WB) testing includes:

[0083] Place the cell sample in a 1.5 mL EP tube, add 1 mL RIPA, 10 μL PMSF, and 20 μL phosphatase inhibitor, lyse at 4°C for 1 h, centrifuge at 12,000 rpm for 5 min, and perform BCA quantification on the cell sample (refer to the instructions of the YEASEN BCA protein quantification kit) to detect the protein expression level. The specific operation method is as follows:

[0084] (1) PAGE gel preparation

[0085] Refer to the instructions of the YEASEN gel kit, generally 12% separation gel and 5% concentration gel; use 1.0 mm glass plate for configuration; add 1 mL of isopropanol to the glass plate of the gel rack for sealing, let it stand at room temperature for 35 min, pour out the isopropanol, and absorb the residual isopropanol with filter paper; add the upper layer of concentrated gel, insert the electrophoresis comb and let it stand at room temperature for 35 min.

[0086] (2) Protein sample preparation

[0087] For cell samples, collect cells (such as one dish), centrifuge at 1000 rpm for 5 min, discard the supernatant, add 500 μL PBS to resuspend and 10 μM PMSF (for phosphorylation, phosphatase inhibitors need to be added), add 125 μL 5× Loading Buffer to mix, boil in water bath for 10 min, vortex for 30 s, and centrifuge at 12000 rpm for 3 min.

[0088] (3) Experimental steps

[0089] Take out the gel plate from the gel rack, install it on the electrophoresis rack, and place it in the electrophoresis tank; pour 1×Tris-Gly-SDS electrophoresis buffer until the scale line; pull out the electrophoresis comb and spot the sample; electrophoresis at 75 V for 60 min (bromophenol blue to separation gel), and then electrophoresis at 120 V for 80 min; stop electrophoresis when the bromophenol blue indicator line reaches the bottom; transfer to the membrane, cut the PVDF membrane (usually 4×8 cm specifications) according to the PAGE gel electrophoresis area, then activate it with methanol for 1 min, and then put it in the transfer buffer for 30 s to balance; remove the PAGE gel from the glass plate, place it on the filter paper, mark the membrane, cover it on the gel, remove the bubbles, cover it with filter paper and sponge, close the transfer clamp, pour in the pre-cooled transfer solution, and place the transfer tank in an ice water bath; the transfer electron flow direction is: black plate → sponge → filter paper → gel → membrane → filter paper → sponge → red plate; the transfer condition is a constant current of 125 mA (125 mA for one group and 250 mA for two groups mA, and so on), the time is the molecular weight plus 10 min; blocking: after the transfer is completed, take out the membrane and block it with TBST containing 5% skim milk at room temperature for 1 h (can be kept at 4°C overnight); cutting the membrane: cut the membrane along the Maker; dilute the primary antibody with TBST according to the instructions, incubate at room temperature for 1 h (can be kept at 4°C overnight); after incubation, wash the membrane twice with 1×TBST, 10 min each time; dilute the secondary antibody with TBST according to the instructions (goat anti-mouse: 1:20000 dilution, goat anti-rabbit: 1:20000 dilution), incubate at room temperature for 1 h; after incubation, wash the membrane twice with 1×TBST, 10 min each time; exposure (using ECL chemiluminescence, 2 mL of A solution + 2 mL of B solution, soak the membrane, and use the instrument to expose).

[0090] In this application, unless otherwise specified, RT-qPCR testing includes:

[0091] (1) Extraction of total RNA using Trizol

[0092] Add 1 mL of Trizol to the cells, pipette and mix, place at 4°C for 15 min to allow for full lysis, and then transfer to a 1.5 mL centrifuge tube;

[0093] Chloroform was added at a rate of 200 μL chloroform / mL Trizol, and the mixture was shaken vigorously for 30 s, and then allowed to stand at 4°C for 15 min;

[0094] Centrifuge at 12,000 rpm for 15 min at 4°C in a desktop centrifuge until the solution is fully separated;

[0095] 400 μL of supernatant was carefully transferred to a sterile 1.5 RNase-free centrifuge tube, 400 μL of isopropanol was added, mixed, and precipitated at room temperature for 40 min;

[0096] Centrifuge at 12,000 rpm for 15 min at 4°C on a desktop centrifuge and discard the supernatant;

[0097] Add 1 mL of 75% ethanol and wash twice, centrifuge at 12000 rpm for 5 min at 4°C, and discard the supernatant;

[0098] After the ethanol evaporated in the clean bench, 30 μL of DEPC water was added to dissolve the RNA and stored at -80°C for later use.

[0099] (2) Reverse transcription of cDNA (refer to the YEASEN reverse transcription instructions)

[0100] (3) Fluorescence quantitative PCR

[0101] The total volume of the reaction system is 20 μL:

[0102] Hieff® qPCR SYBR Green Master Mix (Low Rox Plus), 10 μL; ForwardPrimer (10μM), 0.5 μL; Reverse Primer (10μM), 0.5 μL; cDNA, 1 μL; ddH2O to 20 μL.

[0103] Setting of fluorescence quantitative PCR amplification conditions:

[0104] Amplification curve: 95℃ 5 min, 1 cycle; 95℃ 10 s, 60℃ 20 s, 72℃ 31 s, 40 cycles; melting curve: 95℃ 15 s, 60℃ 30 s, 95℃ 15 s.

[0105] In this application, the different components of rainbow trout include:

[0106] Tissues: Fish meat (muscle tissue, which makes up the majority of the fish's body); fish oil (fatty tissue, which is found in fish, especially in the abdomen and around the internal organs); fish bones (special connective tissue, bones are connected together by joints, and together form a complex skeletal system or skeleton);

[0107] Organs: fish heart, fish liver, fish maw (fish stomach), fish skin, fish bladder;

[0108] Part: Fish head (including brain, eyes, nose, mouth and other organs).

[0109] Example 1

[0110] This example provides an analysis of the protein and polypeptide content of different components of rainbow trout.

[0111] In this embodiment, the different components of rainbow trout include: fish meat, fish oil, fish bones, fish heart, fish liver, fish belly, fish skin, fish bladder and fish head.

[0112] In this embodiment, the rainbow trout was sourced from Xinjiang Tianyun Organic Agriculture Co., Ltd. (Nileke County, Yili, Xinjiang).

[0113] In this example, the analysis of protein and polypeptide content is to sample different components of rainbow trout, add PMSF (phenylmethylsulfonyl fluoride), a serine protease inhibitor, and use RIPA lysis buffer (RadioImmunoprecipitation Assay Lysis Buffer) to strongly lyse the animal cell membrane, cytoplasm, and nuclear components. The RIPA lysis buffer is mixed with the tissue block and frozen and ground, and centrifuged at 14800 rpm for 5 min to obtain a crude protein extract solution of each component of rainbow trout; then, based on the BCA protein quantification principle, the highest absorbance is measured at a wavelength of 562 nm using an enzyme marker, and the sample protein and polypeptide content is calculated by comparing the standard curve. Specifically including:

[0114] (1) Take out the tissue blocks of each component of rainbow trout from the -80℃ freezer and quickly put them into a 4℃ refrigerator to thaw;

[0115] (2) Wash each tissue block with PBS (Wuhan Sewell Biotechnology Co., Ltd.) until the surface of the tissue block is smooth and free of blood;

[0116] (3) Accurately weigh 4 pieces of 150 mg tissue samples of each of the nine components using an analytical balance and place them into a grinding tube;

[0117] (4) Add 2% volume of PMSF (20104ES03, Yisheng Biotechnology (Shanghai) Co., Ltd.) to RIPA lysis buffer (20101ES60, Yisheng Biotechnology (Shanghai) Co., Ltd.), then add the corresponding volume of RIPA lysis buffer containing PMSF to the grinding tube at a ratio of 1 mg sample: 10 μL RIPA lysis buffer, and then add 5 grinding beads to the grinding tube;

[0118] (5) Frozen grinding mechanism homogenization, homogenization conditions: temperature -20 °C, running time 300 s, interruption time 30 s, grinding times 2 times, frequency 60 Hz;

[0119] (6) Centrifugation in a low-temperature centrifuge. The centrifugation conditions were: temperature 4°C, speed 14800 rpm, and time 5 min.

[0120] (7) Discard the upper fat layer and the lower sediment layer, and transfer the crude protein extract with a pipette;

[0121] (8) According to the BCA protein concentration kit (20201ES76, Yisheng Biotechnology (Shanghai) Co., Ltd.), use an ELISA reader to measure the maximum absorbance of the crude protein extract at a wavelength of 562 nm, and calculate the protein polypeptide content of the sample by comparing it with the standard curve.

[0122] Result analysis:

[0123] The protein polypeptide contents of the nine components of rainbow trout are shown in Table 3. The protein polypeptide contents of the tripe, liver, skin and heart of rainbow trout are relatively high, while the protein polypeptide contents of oil and bones are relatively low.

[0124] Table 3 Protein and polypeptide contents of nine components of rainbow trout

[0125]

[0126] Example 2

[0127] This example provides composition analysis and function prediction of protein polypeptides from different components of rainbow trout.

[0128] In this embodiment, the different components of rainbow trout include: fish meat, fish oil, fish bones, fish heart, fish liver, fish belly, fish skin, fish bladder and fish head.

[0129] In this embodiment, the composition analysis and function prediction of protein polypeptides is to obtain the crude whole protein solution of each component of rainbow trout, sequence the crude whole protein solution sample using LC-MS technology, and compare the sequence homology with the rainbow trout proteome and human proteome in the UniProt database (there is less functional information of the rainbow trout proteome in the database), search the functions of protein polypeptides in sequence according to the ranking order of the compared sequences, and predict the functions of the protein polypeptides of each component of rainbow trout according to the functions recorded in the UniProt database. Specifically including:

[0130] (1) SDS-PAGE

[0131] Prepare samples: According to the quantitative results in Example 1, take an equal amount of 10 μg of each protein crude extract sample, add 4× Loading buffer, and boil in a boiling water bath for 5 min;

[0132] Prepare gel: Prepare gel according to Table 4,

[0133] Table 4 SDS-PAGE gel preparation

[0134]

[0135] Sample loading: First run at a constant voltage of 80 V to the boundary between the concentrated gel and the separation gel, then change the voltage to 120 V and run at a constant voltage until the bromophenol blue runs to the bottom of the gel;

[0136] Coomassie Brilliant Blue Staining: including Coomassie staining and rinsing, the procedure is shown in Table 5.

[0137] Table 5 Coomassie Brilliant Blue Staining Procedure

[0138]

[0139] Gel scanning and storage: Ensure that each gel is scanned in the same direction, the scanning mode is 256 grayscale perspective scanning, and the resolution is 200 dpi. The scanned gel is wrapped in plastic wrap and stored at 4°C.

[0140] (2) Protease cleavage

[0141] 30 μg of crude protein extract was added with 4 μL 0.05 M TCEP solution, and the reaction was reduced at 60°C for 1 h. After reduction, 2 μL 55 mM MMTS solution was added, and the reaction was kept at room temperature and protected from light for 45 min. The protein solution was added to a 10KDa ultrafiltration tube and centrifuged at 12,000 g for 20 min. 100 μL UA (8 M urea pH 8.5) solution was added, and the reaction was centrifuged at 12,000 g for 20 min, twice. 100 μL 0.25 M TEAB was added, and the reaction was centrifuged at 12,000 g for 20 min, and repeated three times. 50 μL 0.5 M TEAB was added, and 2% trypsin (the ratio of trypsin to protein was 1:50, and trypsin was purchased from Thermo Fisher Scientific, catalog number 90057) was added, and the reaction was incubated at 37°C for 12 h. 1% trypsin (the ratio of trypsin to protein was 1:100) was added again, and the reaction was incubated at 37°C for 4 h; replace a new collection tube, collect the filtrate by centrifugation, and dry it under vacuum at 20°C to obtain the peptide fragments.

[0142] (3) Mass spectrometry detection

[0143] (A) The peptides were dissolved in sample dissolving solution (0.1% formic acid, 2% acetonitrile), centrifuged at 13200 rpm, 4°C for 20 min, and the supernatant was collected for mass spectrometry identification;

[0144] (B) Liquid phase parameters:

[0145] (a) Column information:

[0146] Acclaim™ PepMap™ C18 reversed-phase HPLC column, 5 μm, 0.3 mm×5 mm (Thermo, 160454);

[0147] Acclaim™ PepMap™ C18 reversed-phase HPLC column, 3 μm, 0.075 mm×150 mm (Thermo, 160321);

[0148] (b) Mobile phase information

[0149] Mobile phase A: 0.1% formic acid,

[0150] Mobile phase B: 0.1% formic acid, 80% cerium ammonium nitrate (CAN),

[0151] Flow rate: 300 nL / min;

[0152] (c) Analysis time: 90 min;

[0153] (d) Effective gradient: Phase B increases from 5% to 90%, as shown in Table 6:

[0154] Table 6 Liquid chromatography mobile phase B gradient settings

[0155]

[0156] (C) Mass spectrometry parameters

[0157] The separated peptides were directly fed into the mass spectrometer Thermo Scientific Q Exactive for online detection. The specific parameters were as follows:

[0158] (a) Primary mass spectrometry parameters

[0159] Resolution: 70000,

[0160] AGC target: 3e6,

[0161] Maxim μM IT: 100 ms,

[0162] Scan range: 300 to 1800 m / z;

[0163] (b) Secondary mass spectrometry parameters

[0164] Resolution: 17500,

[0165] AGC target: 5e4,

[0166] Maxim μM IT: 120 ms,

[0167] TopN:20,

[0168] NCE / stepped NCE:30.

[0169] (4) Database search

[0170] The original mass spectrometry file was converted by MM File Conversion software to obtain MGF format file, and then used MASCOT ( http: / / www.matrixscience.com / ) was searched in the UniProt database (Oncorhynchus mykiss, https: / / www.uniprot.org / taxonomy / 8022), and the search parameters are shown in Table 7:

[0171] Table 7 Database search settings

[0172]

[0173] (5) Protein and peptide homology comparison (Blastp) and protein function prediction

[0174] Extract the protein numbers from the mass spectrometry results and input them into the Uniprot platform. After the protein FASTA format sequence comes out, check Homo Sapiens in the species option, click BLAST, and finally obtain the protein comparison results.

[0175] The human proteins with the highest scores and high homology were screened from the comparison results, and based on the functions of human homologous proteins, similar functions that the protein polypeptides in rainbow trout may play in the human body were predicted.

[0176] Result analysis:

[0177] The LC-MS sequencing results of the protein peptides of the nine components of rainbow trout are detailed in Tables 8-16. The table contains the functions of the TOP20 proteins in rainbow trout and the functions of their homologous proteins (human) in humans. Based on the results of protein sequencing and homology comparison, the functions of the TOP20 proteins ranked by comprehensive scores were analyzed and predicted, indicating that the components of rainbow trout have the following potential functions:

[0178] Fish protein peptides can fight fatigue;

[0179] Fish bone protein peptides can promote immunity, promote male gonadal development, promote wound healing and blood vessel regeneration;

[0180] Fish heart protein peptide can resist fatigue and improve anemia;

[0181] Fish liver protein peptides can resist oxidation, inflammation, improve anemia, and alleviate formaldehyde and ethanol toxicity;

[0182] Fish maw protein peptides can promote wound healing and angiogenesis, fight tumors, and improve immunity;

[0183] Fish skin protein peptides can improve vision and hearing, boost immunity, and promote male gonad development;

[0184] Fish bladder protein peptides can promote immunity, anti-mutation, anti-bacteria, anti-inflammation, and improve anemia;

[0185] Fish head protein peptides can promote hearing improvement, immunity improvement, anti-mutation, anti-bacteria, and anti-inflammation;

[0186] The content of fish oil protein polypeptide is low, and the comparison results do not show that it has a clear active function.

[0187] Table 8 Functional analysis and prediction of the top 20 proteins ranked by comprehensive scores in rainbow trout meat

[0188]

[0189]

[0190] Table 9 Functional analysis and prediction of the top 20 proteins ranked by comprehensive scores in rainbow trout bones

[0191]

[0192] Table 10 Functional analysis and prediction of the top 20 proteins ranked by comprehensive scores in rainbow trout heart

[0193]

[0194] Table 11 Functional analysis and prediction of the top 20 proteins ranked by comprehensive scores in rainbow trout liver

[0195]

[0196] Table 12 Functional analysis and prediction of the top 20 proteins ranked by comprehensive scores in rainbow trout belly

[0197]

[0198] Table 13 Functional analysis and prediction of the top 20 proteins ranked by comprehensive scores in rainbow trout skin

[0199]

[0200] Table 14 Functional analysis and prediction of the top 20 proteins ranked by comprehensive scores in rainbow trout swim bladder

[0201]

[0202] Table 15 Functional analysis and prediction of the top 20 proteins ranked by comprehensive scores in rainbow trout heads

[0203]

[0204] Table 16 Functional analysis and prediction of the top 20 proteins ranked by comprehensive scores in rainbow trout oil

[0205]

[0206] Example 3

[0207] This embodiment provides a rainbow trout-derived polypeptide extract and a preparation method thereof.

[0208] Rainbow trout polypeptide extract is prepared by enzymatic hydrolysis using one or more of the different components of rainbow trout such as fish meat, fish oil, fish bones, fish heart, fish liver, fish maw, fish skin, fish bladder and fish head as protein raw materials. The preparation method includes the steps of raw material pretreatment, enzymatic hydrolysis, defatting and deodorization, membrane filtration and sterilization, concentration, spray drying, etc., specifically including:

[0209] (1) Raw material pretreatment: The protein raw material (a certain component of rainbow trout or a mixture of several components) is thawed naturally at room temperature, and the thawed protein raw material is repeatedly rinsed to remove blood and other impurities, and then the rinsed protein raw material is passed through a meat grinder and a colloid mill (Shandong Ruiliang Food Industry Equipment Co., Ltd.) to make it fluid, thereby obtaining a fluid protein raw material; if the protein raw material is fresh, rather than frozen, it is directly rinsed to remove blood and other impurities, and then the rinsed protein raw material is passed through a meat grinder and a colloid mill;

[0210] (2) Enzymatic hydrolysis: Put the fluid protein raw material into an enzymatic hydrolysis tank, and add water at a mass ratio of 1:2 between the protein raw material and water; heat the enzymatic hydrolysis tank to 58°C, add 0.2% of the mass of the protein raw material compound protease (Shanghai Yuanye Biotechnology Co., Ltd.; S10155), and stir continuously at this temperature for 3 hours to hydrolyze the protein raw material into protein peptides, thus completing the enzymatic hydrolysis; then heat the tank to 100°C and stir for 1 hour to inactivate the enzyme, thereby obtaining an enzymatic hydrolyzate liquid;

[0211] (3) Defatting and deodorizing: The enzymatic hydrolyzate liquid is sieved (500 mesh) and centrifuged (12000 r / min~16000 r / min) to remove impurities such as broken bones (if any) to obtain a protein polypeptide liquid; the protein polypeptide liquid is placed in an oil-water separation centrifuge and centrifuged at 8000 r / min~10000 r / min to perform defatting treatment to obtain a protein polypeptide clear liquid; activated carbon adsorption (6% activated carbon powder, heated to not less than 80°C for adsorption) is used to remove bitter and fishy substances and color in the protein polypeptide clear liquid to finally obtain a polypeptide liquid; in this step, the separation and purification of the protein polypeptide is simultaneously completed;

[0212] (4) Membrane filtration sterilization: Use a microfiltration or ultrafiltration device with a membrane pore size of 0.05-0.1 μm, filter at an operating pressure of 0.2Mpa-0.4Mpa and a temperature of 30-80°C to obtain a clear membrane-filtered polypeptide liquid;

[0213] (5) Concentration: Use a double-effect falling film evaporator to evaporate and concentrate the membrane filtered polypeptide liquid at a steam pressure of 0.1±0.02 MPa and 40~80°C until the solid content of the concentrate is 20%~50%;

[0214] (6) Spray drying: The concentrated liquid is spray dried using a spray drying device. The drying conditions are set at an inlet temperature of 160-180°C and an outlet temperature of 80-90°C to obtain a small molecule, high-purity rainbow trout-derived polypeptide powder, i.e., a rainbow trout-derived polypeptide extract.

[0215] In an embodiment, the above method may further include: packaging the polypeptide peptide powder into finished products in a clean room for easy sale, etc.

[0216] In an embodiment,

[0217] A rainbow trout-derived polypeptide extract 1 (also referred to as polypeptide sample 1) was obtained by mixing three components of rainbow trout meat, fish bones and fish heads (mass ratio was 1:1:1) as protein raw materials;

[0218] A rainbow trout-derived polypeptide extract 2 (also referred to as polypeptide sample 2) was obtained by mixing four components of rainbow trout heart, liver, maw and swim bladder (mass ratio was 1:1:1:1) as protein raw materials;

[0219] Rainbow trout source polypeptide extract 3 (also referred to as polypeptide sample 3) was obtained by mixing four components of rainbow trout meat, fish bones, fish skin and fish head (mass ratio of 1:1:1:1) as protein raw materials.

[0220] Right now:

[0221] Rainbow trout derived peptide extract 1, peptide samples extracted from rainbow trout meat, bones and heads;

[0222] Rainbow trout derived peptide extract 2, peptide samples extracted from the heart, liver, belly and swim bladder of rainbow trout;

[0223] Rainbow trout source peptide extract 3, extracted from the peptide samples of rainbow trout meat, fish bones, fish skin and fish head.

[0224] Example 4

[0225] This example provides verification of the gonadotropin development activity function of rainbow trout-derived polypeptide extract.

[0226] In this embodiment, the rainbow trout-derived polypeptide extract includes the rainbow trout-derived polypeptide extract 1 (polypeptide sample 1), the rainbow trout-derived polypeptide extract 2 (polypeptide sample 2) and the rainbow trout-derived polypeptide extract 3 (polypeptide sample 3) prepared in Example 3.

[0227] In this embodiment, the verification of gonadotropin development activity function includes:

[0228] (1) Screening of peptide sample concentration

[0229] TM4 cells were cultured in DMEM medium (Thermo Fisher Scientific) containing 10% fetal bovine serum (FBS, Thermo Fisher Scientific) at 37°C and 5% CO2 and plated into 96-well plates (1 × 10 4 cell), when the confluence reached 80%, peptide samples were added (peptide sample 1, 300, 600, 1000, 3000, 6000 μg / mL); culture was continued for 24 h; then 10 μL of CCK8 reagent (Shanghai Biotech Co., Ltd.) was added to each well and treated at 37°C for 1 h. The OD value at 450 absorbance was detected by a microplate reader. The cell viability can be calculated by comparing the OD values ​​of the treatment group and the control group. The conversion relationship is: cell viability = (OD value of the treatment group / OD value of the control group) × 100%.

[0230] Result analysis:

[0231] like Figure 1As shown, after the peptide sample 1 treated the TM4 cells, the cell proliferation was obvious, indicating that the peptide sample 1 could promote cell activity, and the 6 mg / mL treatment concentration was selected for subsequent experiments.

[0232] (2) TM4 cell in vitro experiments

[0233] TM4 cells were cultured in DMEM medium containing 10% FBS at 37°C and 5% CO2 and plated into 96-well plates (1×10 4 When the confluence reached 80%, dihydrotestosterone (10 μM, Beijing Solebow Technology Co., Ltd.), androgen inhibitor Bicalutamide (10 μM, MedChemexpress Biotechnology Co., Ltd., USA) and peptide samples (peptide sample 1, peptide sample 2, peptide sample 3, 6 mg / mL) were added in advance for 2 h, and then treated with 10 μM androgen inhibitor for 24 h. Then, 10 μL of CCK8 reagent was added to each well and treated at 37°C for 1 h. The OD value at absorbance of 450 was detected by microplate reader.

[0234] TM4 cells were cultured in DMEM medium containing 10% FBS at 37°C and 5% CO2 and plated into 96-well plates (1×10 4 When the confluence reached 80%, dihydrotestosterone (10 μM), androgen inhibitor Bicalutamide (10 μM), and peptide samples (peptide sample 1, peptide sample 2, and peptide sample 3, 6 mg / mL) were added in advance for 2 h, and then treated with 10 μM androgen inhibitor for 24 h. The cells were digested and collected with 0.25% trypsin (Thermo Fisher Scientific, 25200056) and counted by trypan blue staining. Total cell protein was extracted using RIPA lysis buffer (20101ES60, Yisheng Biotechnology (Shanghai) Co., Ltd.), and the expression of SOX9 and AMH was detected by WB (Abcam (Shanghai) Trading Co., Ltd., ab185966, ab313767). RNA was extracted using Trizol lysis buffer (Thermo Fisher Scientific, 15596018CN), and the transcription of SOX9 and AMH was detected by RT-qPCR. SOX9, as a sex-determining (testis-determining) gene, is downregulated at the transcriptional and translational levels after the birth of mammals, indicating the proliferation of testicular supporting cells and testicular interstitial cells and spermatogenesis; AMH, the anti-Mullerian hormone gene, is essential for sex differentiation. After the birth of mammals, the downregulation of AMH at the transcriptional and translational levels indicates that the function of male testicular interstitial cells is improved.

[0235] Result analysis:

[0236] Effects of androgen, androgen inhibitor and peptide sample treatment on cell proliferation in TM4 gonadal development model Figure 2 As shown, after the three peptide samples were treated separately, peptide sample 2 could slightly increase cell activity.

[0237] WB detection of the effects of three peptide samples on the expression of genes related to gonadal development in TM4 cells after treatment with androgen inhibitors. Figure 3 As shown in the figure, after the three samples were treated separately, compared with the blank group, they were able to reduce the expression of SOX9 and AMH. For SOX9, the reduction effect of peptide sample 1 and peptide sample 2 was more significant; for AMH, the reduction effect of peptide sample 2 and peptide sample 3 was more significant.

[0238] RT-qPCR detection of the effects of three peptide samples on the transcription of genes related to gonadal development in TM4 cells after treatment with androgen inhibitors. Figure 4 As shown, after the three samples were treated separately, peptide sample 2 and peptide sample 3 were able to reduce the transcription of SOX9 and AMH, among which peptide sample 2 had the best effect.

[0239] The above results show that in terms of gonadotropin development, polypeptide extract 2 and polypeptide extract 3 can reduce the transcription and expression of SOX9, among which polypeptide extract 2 has a better effect, followed by polypeptide extract 3. In the protein sequencing and bioinformatics analysis of various components of rainbow trout, it was predicted that rainbow trout bones and skin may have the effect of improving male gonadal development, but the experimental results showed that polypeptide extract 2 extracted from rainbow trout heart, liver, tripe, and swim bladder was more effective than polypeptide extract 1 extracted from rainbow trout meat, bones, and head and polypeptide extract 3 extracted from rainbow trout meat, bones, skin, and head.

[0240] Example 5

[0241] This example provides verification of the immune-enhancing activity of rainbow trout-derived polypeptide extract.

[0242] In this embodiment, the rainbow trout-derived polypeptide extract includes the rainbow trout-derived polypeptide extract 1 (polypeptide sample 1), the rainbow trout-derived polypeptide extract 2 (polypeptide sample 2) and the rainbow trout-derived polypeptide extract 3 (polypeptide sample 3) prepared in Example 3.

[0243] In this embodiment, the verification of the function of promoting immunity enhancement activity includes:

[0244] (1) Screening of the effective concentration of peptide extracts

[0245] RAW264.7 cells were cultured in DMEM medium containing 10% FBS at 37°C and 5% CO2 and plated into 96-well plates (1×10 4cell), when the confluence reached 80%, peptide sample 1 (300, 600, 1000, 3000, 6000 μg / mL) was added for pretreatment for 2 h, and then lipopolysaccharide (LPS, Beijing Solebow Technology Co., Ltd., 1 μg / mL) was treated for 24 h; then 10 μL of CCK8 reagent was added to each well and treated at 37℃ for 1 h, and the OD value at 450 absorbance was detected by microplate reader. The cell viability can be calculated by comparing the OD values ​​of the treatment group and the control group. The conversion relationship is: cell viability = (OD value of treatment group / OD value of control group) × 100%.

[0246] Result analysis:

[0247] Effect of peptide extract 1 on the proliferation of RAW264.7 cells treated with LPS by CCK8 Figure 5 As shown, after treatment with peptide sample 1, cell proliferation was obvious and cell activity was promoted. A treatment concentration of 6 mg / mL was selected for subsequent experiments.

[0248] (2) RAW264.7 cell in vitro experiments

[0249] RAW264.7 cells were cultured in DMEM medium containing 10% FBS at 37°C and 5% CO2 and plated into 96-well plates (1×10 4 cell), and plated in 6-well plates (1×10 5 When the confluence reached 80%, LPS (1 μg / mL), peptide sample 1 (6 mg / mL), peptide sample 2 (6 mg / mL), and peptide sample 3 (6 mg / mL) were added for pretreatment for 2 h, and then treated with LPS (1 μg / mL) for 24 h.

[0250] CCK8 detection was performed in a 96-well plate. 10 μL of CCK8 reagent was added to each well and treated at 37°C for 1 h. The OD value at 450 absorbance was detected by a microplate reader. The cell viability could be calculated by comparing the OD values ​​of the treatment group and the control group. The conversion relationship was: cell viability = (OD value of the treatment group / OD value of the control group) × 100%.

[0251] Neutral red detection was performed on a 96-well plate. Neutral red dye was added and cultured for 4 h. Cell lysis solution (glacial acetic acid-anhydrous ethanol, v:v=1:1) was added to each well and lysed at room temperature for 2 h. The absorbance of each well was measured at 540 nm using an ELISA reader to calculate the cell phagocytic index. The phagocytic index (%) = (OD540 value of the experimental group / OD540 value of the control group) × 100%. The phagocytic index is a quantitative indicator of the phagocytic ability of macrophages, and its increase indicates an upregulation of the immune response.

[0252] The supernatant of the 6-well plate cells was collected and NO was detected using a nitric oxide (NO) assay kit (Nanjing Jiancheng Bioengineering Institute). In this application, it is the release of NO from macrophages. NO in the body has a variety of biological functions including signal transduction, and acts as an effector molecule or metabolic regulator. In the response process of inflammatory signals, macrophages will produce more cytokines and NO. The increase in NO release indicates an upregulation of the immune response.

[0253] Result analysis:

[0254] The effects of peptide sample 1, peptide sample 2, and peptide sample 3 on the proliferation of RAW264.7 cells treated with LPS were detected by CCK8. Figure 6 As shown, pretreatment with polypeptide sample 1, polypeptide sample 2, and polypeptide sample 3 can cause RAW264.7 cells to proliferate, especially after pretreatment with polypeptide sample 1, RAW264.7 cells proliferate significantly.

[0255] Neutral red detection of the effects of peptide sample 1, peptide sample 2, and peptide sample 3 on RAW264.7 cells after LPS treatment Figure 7 As shown, peptide sample 1, peptide sample 2, and peptide sample 3 respectively treated and slightly increased the phagocytic level of RAW264.7 induced by LPS.

[0256] Effects of NO detection peptide sample 1, peptide sample 2, and peptide sample 3 on RAW264.7 cells after LPS treatment Figure 8 As shown, compared with the blank control, peptide sample 1, peptide sample 2, and peptide sample 3 can increase the NO content, indicating that the immune activity of macrophages is increased. In particular, after pretreatment with peptide sample 1, the effect of increasing the NO level is close to that of the LPS pretreatment group, which shows that peptide sample 1 is a good immune activator.

[0257] The above results show that in terms of promoting immunity, peptide extract 1, peptide extract 2 and peptide extract 3 can all enhance the activity of immune cells and phagocytic effects, among which peptide extract 1 is the most significant, followed by peptide extract 3 and peptide extract 2. In protein sequencing and bioinformatics analysis, it is predicted that rainbow trout bones, fish skin, fish bladder and fish head may have the effect of promoting immunity. However, the verification results show that peptide extract 3 extracted from fish meat, fish bones, fish skin and fish head is not better than peptide extract 1 extracted from fish meat, fish bones and fish head, indicating that the peptide extract is not a simple mixture of its components.

[0258] Example 6

[0259] This example provides verification of the anemia-improving activity of rainbow trout-derived polypeptide extract.

[0260] In this embodiment, the rainbow trout-derived polypeptide extract includes the rainbow trout-derived polypeptide extract 1 (polypeptide sample 1), the rainbow trout-derived polypeptide extract 2 (polypeptide sample 2) and the rainbow trout-derived polypeptide extract 3 (polypeptide sample 3) prepared in Example 3.

[0261] In this embodiment, the verification of the anemia-improving activity function includes:

[0262] (1) Primary extraction of fetal rat liver-derived hematopoietic stem cells

[0263] Pregnant 13-day C57BL / 6J mice (Jiangsu Ai Ling Fei Biotechnology Co., Ltd.) were killed by spinal dislocation and soaked in 75% alcohol for 10 min. The abdominal skin was carefully cut open with scissors and turned over. Another pair of ophthalmic scissors was used to cut the peritoneum, cut the uterus and remove the embryo. The embryonic liver was carefully separated under a dissecting microscope and placed in a culture dish containing 1% double-antibody PBS for thorough washing. The tissue blocks were cut into approximately 1 mm3 in size with ophthalmic scissors and digested with 0.25% EDTA-trypsin (Thermo Fisher Scientific; 25200056) for 15 min / 0.1% collagenase II (Yi Sheng Biotechnology (Shanghai) Co., Ltd.) for 30 min. DMEM / F12 complete medium (Thermo Fisher Scientific) was then added to terminate the digestion. The suspension was repeatedly pipetted several times and allowed to stand for a few minutes before being passed through a 200 μm mesh. The cells were collected by centrifugation at 1000 rpm for 5 min and placed on a 10 The cells were cultured in a 100 cm culture dish at 37°C, 5% CO2, and 95% humidity. After 24 h of culture, the non-adherent cell suspension was aspirated, and the cells were collected by centrifugation at 1000 rpm for 5 min, resuspended in 1 mL of culture medium, and 100 μL was used for cell flow cytometry to detect the expression of hematopoietic stem cell (HSC) markers such as CD45, CD38, Sca-1, and c-Kit. CD45 and CD38 are common leukocyte antigens 45 and 38, and CD45+CD38- is a characteristic of normal differentiated erythrocyte surface markers; Sca-1+c-Kit+ cells are early stem cells with the function of reconstructing long-term hematopoiesis, while Sca-1-c-Kit+ cells are relatively late differentiated hematopoietic progenitor cells.

[0264] Result analysis:

[0265] The results are as follows Fig. 9 As shown, hematopoietic stem cells account for about 1% of the extracted cells.

[0266] (2) Detection of the ability of peptide samples to induce red blood cells

[0267] The remaining 900 μL of cells in (1) were plated into a 12-well cell culture plate (1×105 cells / well) for hematopoietic stem cell induction.

[0268] Hematopoietic stem cell induction scheme: The culture system was IMDM medium (90% IMDM + 10% FBS + 1% double antibody + 3 IU / mL heparin sodium, 200 μg / mL human transferrin, 3 IU / mL EPO, 10 ng / mL SCF, 1 ng / mL IL-4) (IMDM medium was purchased from Thermo Fisher Scientific, heparin sodium was purchased from MedChemexpress Biotechnology, human transferrin, EPO, SCF, IL-4 were purchased from Papetech Biotechnology Co., Ltd.), and the induction culture was carried out for 10 days.

[0269] After 10 days of induction culture, peptide samples (peptide sample 1, peptide sample 2 and peptide sample 3, 6 mg / mL) were added, and samples were collected after 24 hours for red blood cell flow cytometry identification of CD71, Ter119, and Ter119 + CD71 + Ter119 is an early red blood cell surface marker. + CD71 - It is a characteristic of mature red blood cell surface markers; WB was used to detect the expression of GATA1. The product of GATA1 expression is GATA Binding Protein 1, which plays an important role in erythroid development by regulating the conversion of fetal hemoglobin to adult hemoglobin. Its upregulation indicates the maturation of red blood cells; RT-qPCR was used to detect the transcription of FOG1. FOG1 is the zinc finger protein 1 gene, and its upregulation indicates the differentiation and maturation of red blood cells.

[0270] Result analysis:

[0271] The results of the three peptide samples on regulating the induction of erythropoiesis by liver-derived hematopoietic stem cells are as follows Fig.10 As shown, the three peptide samples can promote the early red blood cells (Ter119 + CD71 + ) and mature erythrocytes (Ter119 + CD71 - ) were generated, among which peptide sample 2 had the most significant effect.

[0272] The results of WB detection of the induction and regulation of red blood cells by three polypeptide samples are as follows Fig.11 As shown, polypeptide sample 1, polypeptide sample 2, and polypeptide sample 3 can promote GATA1 expression after treating red blood cells respectively. Among them, polypeptide sample 2 has the most significant effect on upregulating GATA1 expression.

[0273] The results of RT-qPCR detection of the regulatory effects of three peptide samples on erythrocyte induction are as follows Fig.12 As shown, after polypeptide sample 1, polypeptide sample 2, and polypeptide sample 3 were used to treat red blood cells, polypeptide sample 1 and polypeptide sample 2 upregulated FOG1 transcription.

[0274] The above results show that in terms of improving anemia, all three peptide samples have anti-anemia activity, among which peptide extract 2 has the best effect, followed by peptide extract 1 and peptide extract 3. This is consistent with the prediction of protein sequencing and bioinformatics analysis that rainbow trout heart, liver, and swim bladder may have the effect of improving anemia, so peptide extract 2 can be developed as an anti-anemia related health food.

[0275] Example 7

[0276] This example provides verification of the anti-fatigue activity function of rainbow trout-derived polypeptide extract.

[0277] In this embodiment, the rainbow trout-derived polypeptide extract includes the rainbow trout-derived polypeptide extract 1 (polypeptide sample 1), the rainbow trout-derived polypeptide extract 2 (polypeptide sample 2) and the rainbow trout-derived polypeptide extract 3 (polypeptide sample 3) prepared in Example 3.

[0278] In this embodiment, the verification of the anti-fatigue activity function includes:

[0279] (1) Selection of concentration and time of ISO treatment

[0280] H9c2 cells were cultured in DMEM medium containing 10% FBS at 37°C and 5% CO2. When the confluence reached 80%, they were trypsinized and plated into 6-well plates (2×10 5 cell), 96-well plate (1×10 4 cell); when the confluence reached 80%, the original culture medium was discarded, and DMEM medium without FBS was added to each well. After culturing for 24 hours, the DMEM medium without FBS was discarded, and DMEM medium containing 10% FBS was added. Different concentrations of isoprenaline (ISO, Shanghai Biotime Biotechnology Co., Ltd.) were added to model.

[0281] The cells were collected and RT-qPCR was used to detect ANP and Myh-7. ANP is one of the markers of myocardial hypertrophy and is almost not expressed in normal mammals, but is highly expressed in the myocardium of animals with myocardial hypertrophy. Its upregulation indicates aggravated myocardial fatigue damage. The expression product of Myh7 is MHC. α-MHC and β-MHC are two expression forms of myosin. Myocardial mechanical stretch caused by pressure overload or the production of neurohumoral factors causes myocardial cell hypertrophy, thereby upregulating the expression of β-MHC.

[0282] Result analysis:

[0283] The results of ISO-H9c2 model construction are as follows Fig.13 As shown in the figure, after H9c2 cells were treated with ISO, the expression of ANP and Myh7 was significantly upregulated, indicating that the in vitro anti-fatigue model was successfully constructed; in addition, the expression of ANP and Myh7 was highest after the cells were treated with 100 μM ISO for 24 h, so 100 μM and 24 h were selected as the concentration and time of ISO treatment during modeling.

[0284] (2) Verification of the anti-fatigue activity of rainbow trout peptide extract

[0285] H9c2 cells were cultured in DMEM medium containing 10% FBS at 37°C and 5% CO2. When the confluence reached 80%, they were trypsinized and plated into 6-well plates (2×10 5 cell), 96-well plate (1×10 4 cell); when the confluence reached 80%, the original culture medium was discarded, and DMEM medium without FBS was added to each well. After culturing for 24 hours, the DMEM medium without FBS was discarded, and DMEM medium containing 10% FBS was added. The blank group was added with 100 μM isoprenaline (ISO, Shanghai Biotime Biotechnology Co., Ltd.) for modeling; the experimental group was first treated with peptide sample 1 (3 mg / mL), peptide sample 2 (6 mg / mL), and peptide sample 3 (6 mg / mL) for 2 hours, and then 100 μM ISO was added for modeling. The culture time was 24 hours and 36 hours.

[0286] The cells were harvested and ANP and Myh-7 were detected by RT-qPCR.

[0287] The proteins were collected and LC3 and BCL-2 were detected by WB. LC3 is a marker of the autophagy process and is mainly involved in the formation of autophagosomes. Its downregulation indicates that cell autophagy is weakened, that is, the degree of damage is reduced. BCL2 is an apoptosis precursor protein that can inhibit cell death caused by a variety of cytotoxic factors. Its downregulation indicates that the degree of cell damage is reduced.

[0288] Result analysis:

[0289] RT-qPCR detection of the regulatory effects of three peptide samples on fatigue-related factors Fig.14As shown in the figure, when the three peptide samples were treated for 24 hours, compared with the ISO control group, peptide sample 1, peptide sample 2, and peptide sample 3 could reduce the expression of ANP and Myh7, and the effect of peptide sample 3 was the best. As the time extended to 36 hours, after the action of peptide sample 1, the expression of ANP and Myh7 increased significantly, and far exceeded the control group, indicating that cell fatigue was aggravated; after the action of peptide sample 2, the expression of ANP and Myh7 decreased at 24 hours and 36 hours, indicating that peptide sample 2 had a good anti-fatigue effect; after the action of peptide sample 3, the expression of ANP and Myh7 was basically the same at 24 hours and 36 hours, and maintained at a low level, indicating that peptide sample 3 had the best anti-fatigue effect.

[0290] The results of WB detection of autophagy-related protein LC3 and apoptosis-related protein BCL-2 are as follows Fig.15 and Fig.16 As shown, after treatment with peptide sample 1, LC3 was significantly downregulated, but BCL2 was not significantly downregulated; after treatment with peptide sample 2, both LC3 and BCL2 were significantly downregulated; after treatment with peptide sample 3, BCL2 was significantly downregulated, but LC3 was not significantly downregulated.

[0291] The above results show that both polypeptide extract 2 and polypeptide extract 3 have certain anti-fatigue activity, among which polypeptide extract 3 is the most significant, but polypeptide extract 3 will increase the expression of LC3 and aggravate cell autophagy; polypeptide extract 2 is second but relatively safer and more reliable. This is consistent with the prediction of protein sequencing and bioinformatics analysis that rainbow trout meat and fish heart may have anti-fatigue effects. Therefore, polypeptide extract 2 and polypeptide extract 3 have the potential to be developed as anti-fatigue related health foods, but polypeptide extract 2 may be safer.

Claims

1. A rainbow trout-derived polypeptide extract, It is characterized in that The polypeptide extract is extracted from any of the following mixed rainbow trout components: (1) Rainbow trout meat, bones and head, with the mass ratio of each component being 1:1:1; (2) rainbow trout heart, liver, belly and bladder, with the mass ratio of each component being 1:1:1:1; (3) Rainbow trout meat, bones, skin and head, with the mass ratio of each component being 1:1:1:1; The preparation method of the polypeptide extract comprises the steps of raw material pretreatment, enzymatic hydrolysis, defatting and deodorization, membrane filtration and sterilization, concentration, and spray drying; (1) Raw material pretreatment: several components of rainbow trout are mixed as the protein raw material, which are rinsed clean, and the rinsed protein raw material is passed through a meat grinder and a colloid mill to make it fluid, thereby obtaining a fluid protein raw material; (2) Enzymatic hydrolysis: Put the fluid protein raw material into an enzymatic hydrolysis tank, add water at a mass ratio of protein raw material to water of 1:(1-3); heat the enzymatic hydrolysis tank to 56-60°C, add the composite protease, stir continuously for 3-4 hours to complete the enzymatic hydrolysis; then heat to 100-120°C and stir for 40-60 min to inactivate the enzyme, and obtain an enzymatic hydrolyzate liquid; the composite protease is the composite protease with product number S10155 of Shanghai Yuanye Biotechnology Co., Ltd.; (3) Defatting and deodorizing: The enzymatic hydrolyzate liquid is sieved and centrifuged at 12,000 to 16,000 r / min to obtain a protein polypeptide liquid; the protein polypeptide liquid is placed in an oil-water separation centrifuge and centrifuged at 8,000 to 10,000 r / min to perform defatting treatment to obtain a protein polypeptide clear liquid; the bitter and fishy substances and color in the protein polypeptide clear liquid are removed by activated carbon adsorption to finally obtain a polypeptide liquid; (4) Membrane filtration sterilization: Use a microfiltration or ultrafiltration device with a membrane pore size of 0.05-0.1 μm, filter at an operating pressure of 0.2 Mpa-0.4 Mpa and a temperature of 30-80°C to obtain a clear membrane-filtered polypeptide liquid; (5) Concentration: Use a double-effect falling film evaporator to evaporate and concentrate the membrane filtered polypeptide liquid at a steam pressure of 0.1±0.02 MPa and 40~80°C until the solid content of the concentrate is 20%~50%; (6) Spray drying: The concentrated solution is spray dried using a spray drying device. The drying conditions are set at an inlet temperature of 160-180°C and an outlet temperature of 80-90°C to obtain a rainbow trout-derived polypeptide extract.

2. The rainbow trout-derived polypeptide extract according to claim 1, It is characterized in that The polypeptide extract is extracted from rainbow trout meat, fish bones and fish heads.

3. The rainbow trout-derived polypeptide extract according to claim 1, It is characterized in that The polypeptide extract is extracted from the heart, liver, belly and bladder of rainbow trout.

4. The rainbow trout-derived polypeptide extract according to claim 1, It is characterized in that The polypeptide extract is extracted from rainbow trout meat, fish bones, fish skin and fish head.

5. A method for preparing a rainbow trout-derived polypeptide extract according to any one of claims 1 to 4, It is characterized in that The preparation method comprises the steps of raw material pretreatment, enzymatic hydrolysis, defatting and deodorization, membrane filtration and sterilization, concentration, and spray drying; (1) Raw material pretreatment: several components of rainbow trout mixed together are used as protein raw materials, which are rinsed clean and passed through a meat grinder and a colloid mill to make the rinsed protein raw materials fluid, thereby obtaining fluid protein raw materials; the protein raw materials are selected from any of the following mixed components of rainbow trout: (1) Rainbow trout meat, bones and head, with the mass ratio of each component being 1:1:1; (2) rainbow trout heart, liver, belly and bladder, with the mass ratio of each component being 1:1:1:1; (3) Rainbow trout meat, bones, skin and head, with the mass ratio of each component being 1:1:1:1; (2) Enzymatic hydrolysis: Put the fluid protein raw material into an enzymatic hydrolysis tank, add water at a mass ratio of protein raw material to water of 1:(1-3); heat the enzymatic hydrolysis tank to 56-60°C, add the composite protease, stir continuously for 3-4 hours to complete the enzymatic hydrolysis; then heat to 100-120°C and stir for 40-60 min to inactivate the enzyme, and obtain an enzymatic hydrolyzate liquid; the composite protease is the composite protease with product number S10155 of Shanghai Yuanye Biotechnology Co., Ltd.; (3) Defatting and deodorizing: The enzymatic hydrolyzate liquid is sieved and centrifuged at 12,000 to 16,000 r / min to obtain a protein polypeptide liquid; the protein polypeptide liquid is placed in an oil-water separation centrifuge and centrifuged at 8,000 to 10,000 r / min to perform defatting treatment to obtain a protein polypeptide clear liquid; the bitter and fishy substances and color in the protein polypeptide clear liquid are removed by activated carbon adsorption to finally obtain a polypeptide liquid; (4) Membrane filtration sterilization: Use a microfiltration or ultrafiltration device with a membrane pore size of 0.05-0.1 μm, filter at an operating pressure of 0.2 Mpa-0.4 Mpa and a temperature of 30-80°C to obtain a clear membrane-filtered polypeptide liquid; (5) Concentration: Use a double-effect falling film evaporator to evaporate and concentrate the membrane filtered polypeptide liquid at a steam pressure of 0.1±0.02 MPa and 40~80°C until the solid content of the concentrate is 20%~50%; (6) Spray drying: The concentrated solution is spray dried using a spray drying device. The drying conditions are set at an inlet temperature of 160-180°C and an outlet temperature of 80-90°C to obtain a rainbow trout-derived polypeptide extract.

6. Use of a rainbow trout-derived polypeptide extract according to any one of claims 1 to 4 in the preparation of a drug for improving anemia, or a food for promoting immunity and / or resisting fatigue.

7. The use according to claim 6, It is characterized in that The rainbow trout-derived polypeptide extract is extracted from rainbow trout meat, bones and heads, and is used for preparing a medicine for improving anemia or preparing a food for promoting immunity.

8. The use according to claim 6, It is characterized in that The rainbow trout-derived polypeptide extract is extracted from the heart, liver, belly and bladder of rainbow trout, and is used for preparing a medicine for improving anemia, or preparing a food for promoting immunity and / or resisting fatigue.

9. The use according to claim 6, It is characterized in that The trout-derived polypeptide extract is extracted from the meat, bones, skin and head of rainbow trout, and is used for preparing a medicine for improving anemia, or preparing a food for promoting immunity and / or resisting fatigue.

10. A pharmaceutical composition or health food, It is characterized in that The pharmaceutical composition or health food comprises a rainbow trout-derived polypeptide extract as described in any one of claims 1-4.